Bvf Inc Erytech Pharma S.A. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$4.51 - $7.3 $3.11 Million - $5.03 Million
689,656 Added 110.34%
1,314,656 $6.38 Million
Q4 2017

Feb 14, 2018
BUY
$17.93 - $30.3 $11.2 Million - $18.9 Million
625,000
625,000 $13.8 Million

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email